Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Bristol, AstraZeneca Rebuffed by FDA Panel on Diabetes Drug
Bloomberg
Tue, 07/19/11 - 06:11 pm
Tags:
FDA, AstraZeneca, diabetes, Bristol-Myers Squibb, Dapagliflozin
Regulatory "sword of Damocles" dangles over two big AZ drugs
Fierce Biotech
Tue, 07/19/11 - 01:14 pm
Tags:
AstraZeneca, FDA, Brilinta, blood thinners, Dapagliflozin, Bristol-Myers Squibb
FDA pushes new heart warning on AZ's Seroquel
Fierce Pharma
Tue, 07/19/11 - 12:19 pm
Tags:
AstraZeneca, Seroquel, FDA, warnings, antipsychotics
Eli Lilly: Poised to Reward Patient Investors?
Seeking Alpha
Tue, 07/19/11 - 10:15 am
Tags:
Eli Lilly, investors, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Forest Labs, Impax, Mylan, Teva Pharmaceuticals, Watson Pharmaceuticals
FDA Cites Risks in Diabetes Drug
Motley Fool
Sun, 07/17/11 - 12:04 pm
Tags:
AstraZeneca, Bristol-Myers Squibb, Dapagliflozin, diabetes
High Yield Large-Cap Pharma: Recent Performance and 5-Year Dividend Growth Analysis
Seeking Alpha
Sat, 07/16/11 - 11:45 am
Tags:
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GSK, Merck, Pfizer, Sanofi
FDA Says Bristol-AstraZeneca Diabetes Drug May Cause Cancer
Bloomberg
Fri, 07/15/11 - 02:21 pm
Tags:
FDA, diabetes, Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, bladder cancer
AstraZeneca unit loses patent rights
FT.com
Wed, 07/6/11 - 08:17 am
Tags:
AstraZeneca, patents, Roche, MedImmune, ranibizumab, Novartis
Eli Lilly Reaffirms Commitment to Innovation but Needs to Deliver
Seeking Alpha
Tue, 07/5/11 - 04:37 pm
Tags:
innovation, Eli Lilly, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Merck, Novartis, Pfizer, Roche, Sanofi
Par Restructures Branded Business
Yahoo/Zacks.com
Tue, 07/5/11 - 10:56 am
Tags:
Par Pharmaceutical, reorganization, AstraZeneca
July Catalysts for Biotech and Drug Stocks
Minyanville
Tue, 07/5/11 - 09:58 am
Tags:
Seattle Genetics, Bristol-Myers Squibb, JNJ, advisory panels, FDA, Transcept, AstraZeneca, GSK, Human Genome Sciences, Merck, Theravance, Amgen, Biogen Idec, Acorda Therapeutics
Dentsply Acquisition Delivers Smiles
Motley Fool
Mon, 07/4/11 - 09:11 am
Tags:
M&A, Dentsply, AstraZeneca, dental, Astra Tech
3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review
Motley Fool
Fri, 07/1/11 - 09:44 am
Tags:
FDA, Bristol-Myers Squibb, AstraZeneca, Pfizer, Incyte, Novartis, ruxolitinib, Apixaban, Dapagliflozin
6 Healthcare Companies With July Catalysts
Seeking Alpha
Thu, 06/30/11 - 07:26 pm
Tags:
Alexa, AstraZeneca, Bristol-Myers Squibb, JNJ, Seattle Genetics, Transcept
Study points to possible aspirin link with Astra heart drug
Reuters
Tue, 06/28/11 - 11:38 pm
Tags:
AstraZeneca, Brilinta, aspirin
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Bloomberg
Mon, 06/27/11 - 05:53 pm
Tags:
Brilinta, AstraZeneca, aspirin, Plavix, Sanofi, Bristol-Myers Squibb
Life Technologies Ties Up with Pharma Majors
Yahoo/Zacks.com
Mon, 06/27/11 - 10:36 am
Tags:
Life Technologies, AstraZeneca, Illumina, JNJ
Bristol-Myers, AstraZeneca Diabetes Drug Shows Bladder, Breast Cancer Risk
Bloomberg
Sun, 06/26/11 - 12:09 pm
Tags:
Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, diabetes
AstraZeneca: Dividend Dynamo or Blowup?
Motley Fool
Sat, 06/25/11 - 08:59 pm
Tags:
AstraZeneca
Bristol-Myers Experimental Diabetes Drug Safe After 2 Years, Study Shows
Bloomberg
Sat, 06/25/11 - 08:44 pm
Tags:
Bristol-Myers Squibb, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.